Copyright
©2006 Baishideng Publishing Group Co.
World J Gastroenterol. Jan 7, 2006; 12(1): 157-158
Published online Jan 7, 2006. doi: 10.3748/wjg.v12.i1.157
Published online Jan 7, 2006. doi: 10.3748/wjg.v12.i1.157
Figure 1 The positions of electrodes for EGG recording.
X, xyphoid process; N, navel; RMCL, right mid-clavicular line; LMCL, left mid-clavicular line; C, central terminal electrode placed on the patient's ventral midline about halfway between the umbilicus and the xyphoid process; A, channel 1 placed on an intersecting point between RMCL and a vertical bisectrix of the line XC; B, channel 2 placed on intersecting point between LMCL and a vertical bisectrix of the line XC; D, channel 3 placed on intersecting point between RMCL and a vertical bisectrix of the line NC; E, channel 4 placed on intersecting point between LMCL and a vertical bisectrix of the line NC.
- Citation: Kinekawa F, Matsuda K, Masaki T, Kurokohchi K, Yoneyama H, Inoue H, Kurata H, Uchida Y, Watanabe S, Kuriyama S. Percutaneous local therapies for hepatocellular carcinoma impair gastric function. World J Gastroenterol 2006; 12(1): 157-158
- URL: https://www.wjgnet.com/1007-9327/full/v12/i1/157.htm
- DOI: https://dx.doi.org/10.3748/wjg.v12.i1.157